de-Assis EM, Pimenta
LGGS, Costa-e-Silva E, Souza PEA, Horta MCR.Stromal myofibroblasts in oral leukoplakia and oral squamous
cell carcinoma. Med Oral Patol
Oral Cir Bucal. 2012 Sep 1;17
(5):e733-8.
doi:10.4317/medoral.17834
http://dx.doi.org/doi:10.4317/medoral.17834
1. Warnakulasuriya S, Johnson NW, van der
Waal I. Nomenclature and classification of potentially malignant disorders of
the oral mucosa. J Oral Pathol Med. 2007;36:575-80.
http://dx.doi.org/10.1111/j.1600-0714.2007.00582.x
2. Napier SS, Speight PM. Natural history of potentially
malignant oral lesions and conditions: an overview of the literature. J Oral Pathol Med. 2008;37:1-10.
http://dx.doi.org/10.1111/j.1600-0714.2007.00579.x
3. Ferlay J, Shin HR, Bray F,
Forman D, Mathers C, Parkin
DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893-917.
http://dx.doi.org/10.1002/ijc.25516
PMid:21351269
4. Krolls SO, Hoffman S. Squamous
cell carcinoma of the oral soft tissues: a statistical analysis of 14.235 cases
by age, sex, and race of patients. J Am Dent Assoc. 1976;92:571-4.
PMid:1062459
5. Scully C. Oral cancer aetiopathogenesis;
past, present and future aspects. Med Oral Patol Oral Cir Bucal. 2011;16:e306-11.
http://dx.doi.org/10.4317/medoral.16.e306
6. Majno G, Gabbiani G, Hirschel BJ, Ryan GB,
Statkov PR. Contraction of granulation tissue in
vitro: similarity to smooth muscle. Science. 1971;173:548-50.
http://dx.doi.org/10.1126/science.173.3996.548
PMid:4327529
7. Desmoulière A, Geinoz A,
Gabbiani F, Gabbiani G.
Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts
and in quiescent and growing cultured fibroblasts. J Cell Biol. 1993;122:103-11.
http://dx.doi.org/10.1083/jcb.122.1.103
PMid:8314838
8. Eyden B. The myofibroblast.
phenotypic characterization as a prerequisite to
understanding its functions in translational medicine. J Cell Mol Med. 2008;12:22-37.
http://dx.doi.org/10.1111/j.1582-4934.2007.00213.x
PMid:18182061
9. Desmoulière A, Guyot C, Gabbiani G. The stroma reaction myofibroblast: a key player in the control of tumor cell
behavior. Int J Dev Biol. 2004;48:509-17.
http://dx.doi.org/10.1387/ijdb.041802ad
PMid:15349825
10. Giatromanolaki A, Sivridis
E, Koukourakis MI. The Pathology of
Tumor Stromatogenesis. Cancer
Biol Ther. 2007;6:639-45.
http://dx.doi.org/10.4161/cbt.6.5.4198
11. Surowiak P, Suchocki S, Györffy B, Gansukh T, Wojnar A, Maciejczyk A, et al. Stromal myofibroblasts in breast cancer: relations between their
occurrence, tumor grade and expression of some tumour
markers. Folia Histochem Cytobiol. 2006;44:111-6.
PMid:16805136
12. Tsujino T, Seshimo I,
Yamamoto H, Ngan CY, Ezumi
K, Takemasa I, et al. Stromal
myofibroblasts predict disease recurrence for
colorectal cancer. Clin Cancer Res. 2007;13:2082-90.
http://dx.doi.org/10.1158/1078-0432.CCR-06-2191
PMid:17404090
13. Kellermann MG, Sobral LM, da Silva SD, Zecchin KG, Graner E, Lopes MA, et al. Myofibroblasts
in the stroma of oral squamous
cell carcinoma are associated with poor prognosis. Histopathology.
2007;51:849-53.
http://dx.doi.org/10.1111/j.1365-2559.2007.02873.x
PMid:18042073
14. Marsh D, Suchak K, Moutasim
KA, Vallath S, Hopper C, Jerjes
W, et al. Stromal features are
predictive of disease mortality in oral cancer patients. J Pathol. 2011;223:470-81.
http://dx.doi.org/10.1002/path.2830
15. De Paula AM, Gomez RS. Immunolocalization of p53,
glutathione S-tranferase pi and CD57 antigens in oral
leukoplakia. Anticancer Res. 2001;21:379-85.
PMid:11299765
16. Bryne M, Koppang HS, Lilleng R, Kjaerheim A.
Malignancy grading of the deep invasive margins of oral squamous
cell carcinomas has high prognostic value. J Pathol. 1992;166:375-81.
http://dx.doi.org/10.1002/path.1711660409
PMid:1517891
17. Liotta LA. Tumor
invasion and metastases - role of the extracellular matrix: Rhoads Memorial
Award lecture. Cancer Res. 1986;46:1-7.
PMid:2998604
18. Fidler IJ. The pathogenesis of cancer metastasis:
the ‘seed and soil’ hypothesis revisited. Nat Rev Cancer.
2003;3:453-8.
http://dx.doi.org/10.1038/nrc1098
PMid:12778135
19. Etemad-Moghadam S, Khalili
M, Tirgary F, Alaeddini M.
Evaluation of myofibroblasts in oral epithelial
dysplasia and squamous cell carcinoma. J Oral Pathol Med. 2009;38:639-43.
http://dx.doi.org/10.1111/j.1600-0714.2009.00768.x
20. Vered M, Allon I, Buchner A, Dayan D. Stromal
myofibroblasts and malignant transformation in a 4NQO
rat tongue carcinogenesis model. Oral Oncol. 2007;43:999-1006.
http://dx.doi.org/10.1016/j.oraloncology.2006.11.007
PMid:17257886
21. Cintorino M, Bellizzi
de Marco E, Leoncini P, Tripodi
SA, Xu LJ, Sappino AP, et
al. Expression of alpha-smooth-muscle actin in stromal cells of the
uterine cervix during epithelial neoplastic changes. Int J Cancer. 1991;47:843-6.
http://dx.doi.org/10.1002/ijc.2910470609
22. Barth PJ, Schenck zu Schweinsberg T, Ramaswamy A, Moll R. CD34+ fibrocytes,
α-smooth
muscle antigen-positive myofibroblasts, and CD117
expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and
larynx. Virchows Arch. 2004;444:231-4.
http://dx.doi.org/10.1007/s00428-003-0965-1
PMid:14758552
23. Lewis MP, Lygoe KA, Nystrom
ML, Anderson WP, Speight PM, Marshall JF, et al. Tumour-derived
TGF-beta1 modulates myofibroblast differentiation and
promotes HGF/SF-dependent invasion of squamous
carcinoma cells. Br J Cancer. 2004;90:822-32.
http://dx.doi.org/10.1038/sj.bjc.6601611
PMid:14970860 PMCid:2410183
24. Kawashiri S, Tanaka A, Noguchi N, Hase T, Nakaya H, Ohara T, et al. Significance of stromal
desmoplasia and myofibroblast
appearance at the invasive front in squamous cell
carcinoma of the oral cavity. Head Neck. 2009;31:1346-53.
http://dx.doi.org/10.1002/hed.21097
25. Vered M, Dobriyan A, Dayan D, Yahalom R, Talmi YP, Bedrin L, et al.
Tumor-host histopathologic variables, stromal myofibroblasts and risk
score, are significantly associated with recurrent disease in tongue cancer.
Cancer Sci. 2010;101:274-80.
http://dx.doi.org/10.1111/j.1349-7006.2009.01357.x
PMid:19804423
26. Kellermann MG, Sobral
LM, da Silva SD, Zecchin
KG, Graner E, Lopes MA, et al. Mutual paracrine effects of oral squamous
cell carcinoma cells and normal oral fibroblasts: Induction of fibroblast to myofibroblast transdifferentiation
and modulation of tumor cell proliferation. Oral Oncol. 2008;44:509-17.
http://dx.doi.org/10.1016/j.oraloncology.2007.07.001
PMid:17826300
27. Logullo AF, Nonogaki S,
Miguel RE, Kowalski LP, Nishimoto IN, Pasini FS, et al. Transforming growth factor beta1
(TGFbeta1) expression in head and neck squamous cell
carcinoma patients as related to prognosis. J Oral Pathol
Med. 2003;32:139-45.
http://dx.doi.org/10.1034/j.1600-0714.2003.00012.x
PMid:12581383
28. Roberts AB, Wakefield LM. The two faces of
transforming growth factor beta in carcinogenesis. Proc Natl
Acad Sci U S A. 2003;100:8621-3.
http://dx.doi.org/10.1073/pnas.1633291100
PMid:12861075 PMCid:166359
29. Bryne M, Jenssen N, Boysen M. Histological grading in the deep invasive front
of T1 and T2 glottic squamous
cell carcinomas has high prognostic value. Virchows
Arch. 1995;427:277-81.
http://dx.doi.org/10.1007/BF00203395
PMid:7496597
30. Sawair FA, Irwin CR, Gordon DJ, Leonard AG,
Stephenson M, Napier SS. Invasive front grading: reliability and usefulness in
the management of oral squamous cell carcinoma. J
Oral Pathol Med. 2003;32:1-9.
http://dx.doi.org/10.1034/j.1600-0714.2003.00060.x
PMid:12558952